Examkin

Soru

Zorluk: ZorEpidemiologic Study Designs

Match each clinical research scenario with the epidemiologic study design that best describes its methodology.

  • Patients with treatment-resistant fibromyalgia receive an experimental medication or placebo for 6 weeks. Following a 3-week medication-free interval, those on the active drug switch to placebo, and vice versa, for another 6 weeks.Crossover randomized controlled trial
  • A study investigates whether a 3-day oral antibiotic regimen for cystitis yields a resolution rate at most 5% worse than a standard 7-day regimen, seeking to justify the shorter course.Non-inferiority clinical trial
  • Investigators recruit 12,500 healthy adults, obtaining baseline biomarker panels. These individuals are monitored biannually over 12 years to determine if elevated baseline biomarkers correlate with future onset of ischemic heart disease.Prospective cohort study
  • After regulatory approval of a novel gene therapy, the manufacturer maintains an ongoing nationwide database of all treated patients to document the incidence of delayed, rare autoimmune complications.Phase IV post-marketing surveillance

Cevap

The fibromyalgia medication switching study is a Crossover randomized controlled trial. The 3-day vs 7-day antibiotic study is a Non-inferiority clinical trial. The 12-year biomarker tracking study is a Prospective cohort study. The national registry for the approved gene therapy is Phase IV post-marketing surveillance.
Each clinical scenario maps to a distinct study design based on its methodology. The fibromyalgia study utilizes a washout period and sequence switching, hallmark features of a crossover trial. The antibiotic study uses a pre-specified margin (5%) to show a shorter regimen is acceptable, defining a non-inferiority trial. The biomarker study measures factors at baseline and follows patients forward in time, characterizing a prospective cohort study. The gene therapy registry tracks real-world safety after approval, which is the definition of Phase IV surveillance.

Adım Adım Çözüm

1
Evaluate the fibromyalgia study methodology.
Identifies sequential treatments separated by a medication-free interval.
This defines a crossover trial where patients serve as their own controls, utilizing a washout period to prevent carryover effects.
2
Evaluate the antibiotic study methodology.
Identifies an acceptable margin of reduced efficacy (5%).
This defines a non-inferiority trial aiming to show a new treatment is not substantially worse than standard care, often to gain secondary benefits like shorter duration.
3
Evaluate the biomarker study methodology.
Identifies baseline measurements followed by forward tracking over time.
This defines a prospective cohort study observing incident disease over time based on prior exposure or biomarker status.
4
Evaluate the gene therapy registry methodology.
Identifies post-approval monitoring for rare adverse events.
This characterizes Phase IV clinical trials, also known as post-marketing surveillance.

Anahtar Kavram

Identifying specific epidemiologic study designs by analyzing subject allocation, temporal tracking, and the primary research objective.
Bu soruyu puanla

Konular

Epidemiologic Study Designs

Bu konudan daha fazla soru